130 related articles for article (PubMed ID: 30774387)
1. ZNF433 positively regulates the beta-catenin/ TCF pathway in prostate cancer and enhances the tumorigenicity of cancer cells.
Gu S; Hou P; Liu K; Niu X; Wei B; Mao F; Xu Z
Onco Targets Ther; 2019; 12():1031-1039. PubMed ID: 30774387
[TBL] [Abstract][Full Text] [Related]
2. TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer.
Yuedi D; Yuankun C; Jiaying Z; Han L; Yueqi W; Houbao L; Dexiang Z
Oncotarget; 2017 Sep; 8(41):70538-70549. PubMed ID: 29050300
[TBL] [Abstract][Full Text] [Related]
3. NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells.
Gu S; Hou P; Liu K; Niu X; Wei B; Mao F; Xu Z
Chem Biol Interact; 2018 Oct; 294():40-47. PubMed ID: 30125550
[TBL] [Abstract][Full Text] [Related]
4. DLX1, a binding protein of beta-catenin, promoted the growth and migration of prostate cancer cells.
Liang M; Sun Y; Yang HL; Zhang B; Wen J; Shi BK
Exp Cell Res; 2018 Feb; 363(1):26-32. PubMed ID: 29317218
[TBL] [Abstract][Full Text] [Related]
5. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
6. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
7. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
Kang DW; Min do S
PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
[TBL] [Abstract][Full Text] [Related]
8. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.
Sun P; Xiong H; Kim TH; Ren B; Zhang Z
Mol Pharmacol; 2006 Feb; 69(2):520-31. PubMed ID: 16291872
[TBL] [Abstract][Full Text] [Related]
9. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
[TBL] [Abstract][Full Text] [Related]
10. TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced β-catenin/TCF-4 transcription.
Gu X; Yao L; Ma G; Cui L; Li Y; Liang W; Zhao B; Li K
Neuro Oncol; 2014 Jan; 16(2):217-27. PubMed ID: 24311645
[TBL] [Abstract][Full Text] [Related]
11. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
[TBL] [Abstract][Full Text] [Related]
12. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.
Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP
J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.
Antony L; van der Schoor F; Dalrymple SL; Isaacs JT
Prostate; 2014 Aug; 74(11):1118-31. PubMed ID: 24913829
[TBL] [Abstract][Full Text] [Related]
14. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy approach in prostate cancer cells using an active Wnt signal.
Giladi N; Dvory-Sobol H; Sagiv E; Kazanov D; Liberman E; Arber N
Biomed Pharmacother; 2007 Oct; 61(9):527-30. PubMed ID: 17904788
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.
Deng YZ; Chen PP; Wang Y; Yin D; Koeffler HP; Li B; Tong XJ; Xie D
J Biol Chem; 2007 Dec; 282(50):36571-81. PubMed ID: 17951630
[TBL] [Abstract][Full Text] [Related]
17. NOP7 interacts with β-catenin and activates β-catenin/TCF signaling in hepatocellular carcinoma cells.
Wu N; Zhao J; Yuan Y; Lu C; Zhu W; Jiang Q
Onco Targets Ther; 2018; 11():6369-6376. PubMed ID: 30319277
[TBL] [Abstract][Full Text] [Related]
18. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
[TBL] [Abstract][Full Text] [Related]
19. Chemical biology reveals CARF as a positive regulator of canonical Wnt signaling by promoting TCF/β-catenin transcriptional activity.
He X; Zhang W; Yan C; Nie F; Li C; Liu X; Fei C; Li S; Song X; Jia Y; Zeng R; Wu D; Pan W; Hao X; Li L
Cell Discov; 2017; 3():17003. PubMed ID: 28417011
[TBL] [Abstract][Full Text] [Related]
20. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
